Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the safety, toxicities, and dosage for
investigational drug Motexafin Gadolinium administered with docetaxel to patients with
advanced solid tumors. Secondly, tumor response to the combined treatment will be evaluated.